Harlan S Robins sold $6.2M of Adaptive Biotechnologies (ADPT)

Executed Mar 11, disclosed Mar 13, 2 days later.

Value, as filed

$6.2M

470,266 sh across 2 lots

Executed

Mar 11

the trade date, as filed

Disclosed

Mar 13

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Harlan S Robins Chief Scientific Officer profile →

Harlan S Robins (Chief Scientific Officer) filed 10 Form 4 reports in the trailing twelve months (0 purchases, 10 sales), most often in Adaptive Biotechnologies Corporation (ADPT). The largest single filing was $10.8M of ADPT (492,400 sh across 2 lots, as filed), executed Jul 21.

The name

ADPT

Adaptive Biotechnologies Corporation ADPT · Healthcare · 80 filings in 24 months ticker →

Healthcare · Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of v…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Harlan S Robins in ADPT

ADPTSALE Adaptive Biotechnologies Corporation $10.8M
492,400 sh across 2 lots
Exec Jul 21
Filed Jul 23 · 7:34 PM ET ADPTSALE Adaptive Biotechnologies Corporation $8.5M
386,240 sh across 2 lots
Exec Jul 2
Filed Jul 7 · 6:52 PM ET ADPTSALE Adaptive Biotechnologies Corporation $1.8M
106,160 sh across 2 lots
Exec Jun 15
Filed Jun 17 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation $148K
10,000 sh × $14.85
Exec Apr 8
Filed Apr 10 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation $392K
24,233 sh across 2 lots
Exec Mar 2
Filed Mar 4 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation $799K
42,788 sh across 2 lots
Exec Feb 2
Filed Feb 4 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation $164K
10,000 sh × $16.44
Exec Jan 6
Filed Jan 8 · 5:30 PM ET ADPTSALE Adaptive Biotechnologies Corporation $673K
37,212 sh across 2 lots
Exec Dec 3 2025
Filed Dec 5 2025 · 5:30 PM ET